Document Detail

Delayed repeated intraperitoneal chemotherapy after cytoreductive surgery for colorectal and appendiceal carcinomatosis.
MedLine Citation:
PMID:  22965403     Owner:  NLM     Status:  In-Data-Review    
BACKGROUND: : Delayed repeated intraperitoneal chemotherapy after cytoreductive surgery for carcinomatosis may be an alternative to intraoperative hyperthermic infusion.
OBJECTIVE: : The aim of this study was to evaluate the safety and feasibility of delayed repeated intraperitoneal chemotherapy after cytoreduction of colorectal and appendiceal carcinomatosis and pseudomyxoma peritonei.
DESIGN: : This study constitutes a retrospective case series.
SETTING: : This study was conducted at a single institution.
PATIENTS: : A total of 31 patients with peritoneal carcinomatosis (23) and pseudomyxoma peritonei (8) were included.
INTERVENTIONS: : Cytoreduction was followed by placement of an adhesion barrier and intraperitoneal catheters. Peritoneal scintigraphy preceded biweekly intraperitoneal 5-fluorouracil and systemic combination chemotherapy with leucovorin, fluorouracil, and oxaliplatin (FOLFOX).
MAIN OUTCOME MEASURES: : The primary outcomes measured are safety, feasibility, and short-term survival.
RESULTS: : Cytoreduction to a score of 0 to 1 was possible in 25 patients (80%). Complications occurred in 16 patients (51.6%) and were confined to grades I to III. There were no deaths, and no digestive fistulae occurred. Port malfunction or complication resulted in removal in 5 patients (16.1%). Intraperitoneal chemotherapy was possible in 83.8% of patients; 55% completed the full course. Peritoneal scintigraphy demonstrated free diffusion of tracer in 18 patients (58%), 4 (12.9%) had diffusion in each gutter with limited communication, 5 (16.1%) had limited diffusion around each catheter without communication, and 2 (6.5%) had no diffusion on scintigraphy. Overall survival for peritoneal carcinomatosis was 44.5% at 3 years (95% CI = 23%-65%).
LIMITATIONS: : The nonrandomized nature of this study and the early experience are limitations.
CONCLUSIONS: : Delayed repeated intraperitoneal and systemic chemotherapy after cytoreduction is feasible and has acceptable morbidity rates. Delayed intraperitoneal chemotherapy is possible in 83% of patients.
Alyssa D Fajardo; Benjamin Tan; Rishindra Reddy; James Fleshman
Related Documents :
12438953 - Lymphomas occurring late after solid-organ transplantation: influence of treatment on t...
1756323 - Intravenous interleukin-2 just after high dose bcnu and autologous bone marrow transpla...
6632893 - Unknown primary melanoma.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Diseases of the colon and rectum     Volume:  55     ISSN:  1530-0358     ISO Abbreviation:  Dis. Colon Rectum     Publication Date:  2012 Oct 
Date Detail:
Created Date:  2012-09-11     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0372764     Medline TA:  Dis Colon Rectum     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1044-52     Citation Subset:  IM    
1Indiana University School of Medicine, Department of Surgery, Indianapolis, Indiana 2Washington University School of Medicine, Department of Surgery, Section of Colon and Rectal Surgery, St Louis, Missouri 3University of Washington School of Medicine, Department of Cardiovascular Surgery, Seattle, Washington.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Juvenile Polyposis Syndrome: A Study of Genotype, Phenotype, and Long-term Outcome.
Next Document:  A randomized controlled trial comparing colonic irrigation and oral antibiotics administration versu...